Xcel Energy Inc
Change company Symbol lookup
Select an option...
XEL Xcel Energy Inc
GE General Electric Co
ADP Automatic Data Processing Inc
CNTB Connect Biopharma Holdings Ltd
SLV iShares Silver Trust
OFSI Omni Financial Services Inc
HBI HanesBrands Inc
SHWDY Resonac Holdings Corp
HKSHY Hongkong and Shanghai Hotels Ltd

Utilities : Electric Utilities | Mid Cap Blend
Company profile

Xcel Energy Inc. is an electric and natural gas delivery company. The Company provides a portfolio of energy-related products and services through its four utility subsidiaries. Its segments include Regulated Electric and Regulated Natural Gas. The Regulated Electric utility segment generates, transmits, and distributes electricity in Minnesota, Wisconsin, Michigan, North Dakota, South Dakota, Colorado, Texas and New Mexico. In addition, it also engaged in the sales for resale and provides wholesale transmission service to various entities in the United States. The Regulated Natural Gas segment transports, stores and distributes natural gas primarily in portions of Minnesota, Wisconsin, North Dakota, Michigan and Colorado. Its utility subsidiaries include NSP-Minnesota, NSP-Wisconsin, Public Service Company of Colorado, and Southwestern Public Service Co. (SPS). The Company also offers residential services, such as heating and cooling solutions and home services.


Last Trade
0.01 (0.01%)
B/A Size

Market Hours

Closing Price
Day's Change
-0.05 (-0.07%)
Bid close
Ask close
B/A Size
Day's High
Day's Low

10-day average volume:

New York poised to award first retail cannabis licenses to drug war casualties instead of big incumbents

1:24 pm ET August 29, 2022 (MarketWatch)

By Steve Gelsi

New York launches applications for conditional adult-use retail dispensaries in a bid to address the wrongs of the War on Drugs

New York State has officially opened up its application process for retail cannabis dispensaries with plans to award the first 150 licenses to people who were imprisoned for cannabis offenses.

It's unclear, however, where the state's large cannabis operators that have been running its medical cannabis dispensaries fit in for now, in a market that could generate up to $15 billion a year in sales.

Unlike other states that awarded the first licenses to larger cannabis companies, the state is instead prioritizing local entrepreneurs who have been locked up for marijuana and also immediate family members of victims of the War on Drugs.

"We're doing what no other state has ever tried," said Chris Alexander, executive director of the New York State Office of Cannabis Management at a Thursday press conference.

Gia Moron, president of Women Grow, said New York is fostering "the most diverse and equitable market in the country."

The application process for the first retail licenses closes on Sept. 26.

Also Read: New York's new cannabis chief vows that half of legal licenses will go to social justice efforts

New York has already been talking to real estate brokers about securing retail locations for the adult-use licensees and even building stores, officials said.

To finance these businesses, the state has set up a $200 million social equity fund.

Cantor Fitzgerald analyst Pablo Zuanic said Friday it's unclear whether New York State's legal cannabis market will provide a "significant source of upside" for larger cannabis companies such as Curaleaf Holdings Inc. , Green Thumb Industries Inc. and Columbia Care Inc. , which is being acquired by Cresco Labs Inc. .

Multistate cannabis operators will be required to pay $20 million to support the state's $200 million social equity fund, Zuanic said.

It's not yet been determined which of the eight license types including cultivation, distribution and retail that medical cannabis incumbents will get, Zuanic said.

"For an established medical registered organization, at this stage it is not clear to what they will be 'grandfathered' [as] just cultivators, and let others do processing as well as wholesale distribution?" Zuanic said.

Ascend Wellness Holdings Inc. said earlier this week the New York market is not a priority currently as it scrapped its acquisition of MedMen's (MMNFF) New York properties.

Green Thumb Industries has sounded "bearish" on New York, although it's building a large cultivation facility in the state, Zuanic said.

Cresco Labs has sounded more upbeat due to the wholesale upside but only if they can play in a profitable and scalable manner but we are not sure this is known at this stage, Zuanic said.

After the initial 150 licenses, the state will sanction additional businesses. It's planning to have the first licensees open for adult use sales by the end of 2022.

While cannabis shares have been weak this year, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) is up about 0.7% on Friday, even as the Nasdaq fell 0.5%.

Also Read: MedMen puts New York business on selling block after Ascend scraps deal

Correction: This story has been updated to remove the wrong firm name for Cantor Fitzgerald analyst Pablo Zuanic.

- Steve Gelsi


(END) Dow Jones Newswires

August 29, 2022 13:24 ET (17:24 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.